Don't overlook PET technologists
I feel obligated to respond to the article in your March 2005 issue, "All clinical sides take hard look at PET and PET/CT" by Halliday et al (page 47). The article overlooks perhaps the most important team member needed to "ensure seamless integration of PET imaging within the hospital system." If the perspective of the nuclear medicine technologist is not taken into account, there will be no success for this venture.
I feel obligated to respond to the article in your March 2005 issue, "All clinical sides take hard look at PET and PET/CT" by Halliday et al (page 47). The article overlooks perhaps the most important team member needed to "ensure seamless integration of PET imaging within the hospital system." If the perspective of the nuclear medicine technologist is not taken into account, there will be no success for this venture.
These techs require additional training, which should be rewarded by additional pay. Their experience and knowledge will produce images that the oncologist, interpreting physician, and hospital/practice administrator can all be happy about.
My hospital has recently added PET/CT to our imaging department. The integration of this modality has been nearly seamless, but only through the hard work and dedication of my technologists, nuclear and CT.
-Lawrence M. McNiesh, M.D.
Chief of Radiology,
Windber Medical Center,
Windber, PA
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
